Epilepsy is estimated to exist in approximately 40% of individuals with cerebral palsy; however, the specific features that make it drug resistant are not well defined. The main aim of this study was to determine the clinical risk factors that could predict drug-resistant epilepsy, in children with cerebral palsy. The study was performed via a retrospective chart review, analyzing clinical parameters of 118 children with cerebral palsy with either drug-resistant epilepsy or controlled epilepsy, between the years 2013 and 2018. We established a predictive model for drug-resistant epilepsy in children with cerebral palsy that is simple to apply in clinical settings and composed of the additive effect of a low Apgar score at 5 minutes, neonatal seizures, focal-onset epilepsy, and focal slowing on electroencephalogram (EEG; area under the receiver operating characteristic of 0.840). Early prediction of drug-resistant epilepsy may benefit to achieve better seizure control in children with cerebral palsy.
RosenbaumPPanethNLevitonA. et al.A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109:8–14.
2.
AshwalSRussmanBSBlascoPA. et al.Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2004;62(6):851–863.
3.
GrahamHKRosenbaumPPanethN. et al.Cerebral palsy. Nat Rev Dis Primers. 2016;2:15082.
4.
HadjipanayisAHadjichristodoulouCYouroukosS. Epilepsy in patients with cerebral palsy. Dev Med Child Neurol. 1997;39(10):659–663.
KwongKLWongSNSoKT. Epilepsy in children with cerebral palsy. Pediatr Neurol. 1998;19(1):31–36.
7.
PahlmanMGillbergCHimmelmannK. One-third of school-aged children with cerebral palsy have neuropsychiatric impairments in a population-based study. Acta Paediatr. 2019;108(11):2048–2055.
8.
SellierEUldallPCaladoE. et al.Epilepsy and cerebral palsy: characteristics and trends in children born in 1976-1998. Eur J Paediatr Neurol. 2012;16(1):48–55.
9.
CarlssonMOlssonIHagbergGBeckungE. Behaviour in children with cerebral palsy with and without epilepsy. Dev Med Child Neurol. 2008;50(10):784–789.
10.
McLellanA. Epilepsy—an additional risk factor for psychological problems in cerebral palsy. Dev Med Child Neurol. 2008;50(10):727.
11.
KulakWSobaniecW. Risk factors and prognosis of epilepsy in children with cerebral palsy in north-eastern Poland. Brain Dev. 2003;25(7):499–506.
12.
SinghiPJagirdarSKhandelwalNMalhiP. Epilepsy in children with cerebral palsy. J Child Neurol. 2003;18(3):174–179.
13.
ZelnikNKonopnickiMBennett-BackOCastel-DeutschTTiroshE. Risk factors for epilepsy in children with cerebral palsy. Eur J Paediatr Neurol. 2010;14(1):67–72.
14.
AksuF. Nature and prognosis of seizures in patients with cerebral palsy. Dev Med Child Neurol. 1990;32(8):661–668.
15.
BruckIAntoniukSASpessattoABemRSHausbergerRPachecoCG. Epilepsy in children with cerebral palsy. Arq Neuropsiquiatr. 2001;59(1):35–39.
16.
CarlssonMHagbergGOlssonI. Clinical and aetiological aspects of epilepsy in children with cerebral palsy. Dev Med Child Neurol. 2003;45(6):371–376.
17.
MertGGIncecikFAltunbasakS. et al.Factors affecting epilepsy development and epilepsy prognosis in cerebral palsy. Pediatr Neurol. 2011;45(2):89–94.
18.
SenbilNSonelBAydinOFGurerYK. Epileptic and non-epileptic cerebral palsy: EEG and cranial imaging findings. Brain Dev. 2002;24(3):166–169.
19.
WallaceSJ. Epilepsy in cerebral palsy. Dev Med Child Neurol. 2001;43(10):713–717.
20.
BeghiECarpioAForsgrenL. et al.Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010;51(4):671–675.
21.
FisherRSAcevedoCArzimanoglouA. et al.ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–482.
22.
FisherRSCrossJHFrenchJA. et al.Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522–530.
23.
SchefferIEBerkovicSCapovillaG. et al.ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512–521.
24.
KwanPArzimanoglouABergAT. et al.Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069–1077.
25.
LaxerKDTrinkaEHirschLJ. et al.The consequences of refractory epilepsy and its treatment. Epilepsy Behav. 2014;37:59–70.
26.
ZafeiriouDIKontopoulosEETsikoulasI. Characteristics and prognosis of epilepsy in children with cerebral palsy. J Child Neurol. 1999;14(5):289–294.
27.
DelgadoMRRielaARMillsJPittABrowneR. Discontinuation of antiepileptic drug treatment after two seizure-free years in children with cerebral palsy. Pediatrics. 1996;97(2):192–197.
28.
SunYVestergaardMPedersenCBChristensenJOlsenJ. Apgar scores and long-term risk of epilepsy. Epidemiology. 2006;17(3):296–301.
29.
Thorngren-JerneckKHerbstA. Low 5-minute Apgar score: a population-based register study of 1 million term births. Obstet Gynecol. 2001;98(1):65–70.
30.
OddingERoebroeckMEStamHJ. The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil Rehabil. 2006;28(4):183–191.
31.
Krageloh-MannIHorberV. The role of magnetic resonance imaging in elucidating the pathogenesis of cerebral palsy: a systematic review. Dev Med Child Neurol. 2007;49(2):144–151.
32.
TowsleyKShevellMIDagenaisLConsortiumR. Population-based study of neuroimaging findings in children with cerebral palsy. Eur J Paediatr Neurol. 2011;15(1):29–35.
GururajAKSztrihaLBenerADawoduAEapenV. Epilepsy in children with cerebral palsy. Seizure. 2003;12(2):110–114.
35.
ShevellMIDagenaisLHallNConsortiumR. Comorbidities in cerebral palsy and their relationship to neurologic subtype and GMFCS level. Neurology. 2009;72(24):2090–2096.
36.
HuangLLiSHeDBaoWLiL. A predictive risk model for medical intractability in epilepsy. Epilepsy Behav. 2014;37:282–286.
37.
WirrellEWong-KisielLMandrekarJNickelsK. Predictors and course of medically intractable epilepsy in young children presenting before 36 months of age: a retrospective, population-based study. Epilepsia. 2012;53(9):1563–1569.
38.
HolmesGLBen-AriY. Seizures in the developing brain: perhaps not so benign after all. Neuron. 1998;21(6):1231–1234.
39.
MosheSLAlbalaBJ. Kindling in developing rats: persistence of seizures into adulthood. Brain Res. 1982;256(1):67–71.
40.
CockerellOCJohnsonALSanderJWShorvonSD. Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia. 1997;38(1):31–46.
41.
ElwesRDJohnsonALShorvonSDReynoldsEH. The prognosis for seizure control in newly diagnosed epilepsy. N Engl J Med. 1984;311(15):944–947.
42.
ArtsWFGeertsATBrouwerOFBoudewyn PetersACStroinkHvan DonselaarCA. The early prognosis of epilepsy in childhood: the prediction of a poor outcome. The Dutch study of epilepsy in childhood. Epilepsia. 1999;40(6):726–734.
43.
De NegriM. Electrical status epilepticus in childhood: neuropsychological impairment and therapeutic management. Dev Med Child Neurol. 1994;36(2):183–186.
44.
BergATShinnarSLevySRTestaFMSmith-RapaportSBeckermanB. Early development of intractable epilepsy in children: a prospective study. Neurology. 2001;56(11):1445–1452.
45.
KoTSHolmesGL. EEG and clinical predictors of medically intractable childhood epilepsy. Clin Neurophysiol. 1999;110(7):1245–1251.
46.
SussovaJSeidlZFaberJ. Hemiparetic forms of cerebral palsy in relation to epilepsy and mental retardation. Dev Med Child Neurol. 1990;32(9):792–795.
47.
AldenkampAPArendsJ. Effects of epileptiform EEG discharges on cognitive function: is the concept of “transient cognitive impairment” still valid?Epilepsy Behav. 2004;5(suppl 1):S25–S34.
48.
JasejaH. Treatment of interictal epileptiform discharges in cerebral palsy patients without clinical epilepsy: hope for a better outcome in prognosis. Clin Neurol Neurosurg. 2007;109(3):221–224.
